Cyclo Therapeutics Inc (CYTH) Stock: What Does the Chart Say Friday?

Cyclo Therapeutics Inc (CYTH) stock has risen 18.13% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator.

Cyclo Therapeutics Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on CYTH!

See Full CYTH Report

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With CYTH Stock Today?

Cyclo Therapeutics Inc (CYTH) stock is trading at $1.89 as of 1:06 PM on Friday, Aug 4, an increase of $0.01, or 0.73% from the previous closing price of $1.88. Volume today is high. So far 137,573 shares have traded compared to average volume of 68,983 shares. The stock has traded between $1.81 and $2.12 so far today. To screen for more stocks like Cyclo Therapeutics Inc click here.

More About Cyclo Therapeutics Inc

Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company develops cyclodextrin-based products for the treatment of disease. Its lead drug candidate, Trappsol Cyclo, treats Niemann-Pick Type C disease (NPC). Its other products include Trappsol HPB, Trappsol Fine Chemical, and Aquaplex. Click Here to get the full Stock Report for Cyclo Therapeutics Inc stock.